Current Role at Stanford

Director, Clinical Research Quality
Spectrum, Stanford Center for Clinical & Translational Research &Education

Find Regulatory Tools on Spectrum's Researcher Resources page.

Service, Volunteer and Community Work

  • Board Member, California Poets in the Schools, California Poets in the Schools (2013 - 2015)


    San Francisco, California

  • Cupertino Poet Laureate, City of Cupertino (10/1/2013 - 9/30/2015)


    Cupertino, California


Work Experience

  • IRB Training Specialist, Stanford University (9/20/2006 - 10/1/2008)

    Stanford University, Research Compliance Office


    Stanford, CA

  • Manager, Regulatory Affairs, Natus Medical, Inc. (1/8/1998 - 2001)


    San Carlos, California


All Publications

  • Recommendations From the Investigational New Drug/Investigational Device Exemption Task Force of the Clinical and Translational Science Award Consortium: Developing and Implementing a Sponsor-Investigators Training Program. Journal of investigative medicine : the official publication of the American Federation for Clinical Research Holbein, M. E., Berglund, J. P., O'Reilly, E. K., Hartman, K., Speicher, L. A., Adamo, J. E., O'Riordan, G., Brown, J. S., Schuff, K. G. 2014; 62 (5): 797?803


    The objective of this study was to provide recommendations for provision of training for sponsor and investigators at Academic Health Centers.A subgroup of the Investigational New Drug/Investigational Device Exemption (IND/IDE) Task Force of the Clinical and Translational Science Award (CTSA) program Regulatory Knowledge Key Function Committee was assembled to specifically address how clinical investigators who hold an IND/IDE and thus assume the role of sponsor-investigators are adequately trained to meet the additional regulatory requirements of this role.The participants who developed the recommendations were representatives of institutions with IND/IDE support programs. Through an informal survey, the task force determined that a variety and mix of models are used to provide support for IND/IDE holders within CTSA institutions. In addition, a CTSA consortium-wide resources survey was used. The participants worked from the models and survey results to develop consensus recommendations to address institutional support, training content, and implementation.The CTSA IND/IDE Task Force recommendations are as follows: (1) Institutions should assess the scope of Food and Drug Administration-regulated research, perform a needs analysis, and provide resources to implement a suitable training program; (2) The model of training program should be tailored to each institution; (3) The training should specifically address the unique role of sponsor-investigators, and the effectiveness of training should be evaluated regularly by methods that fit the model adopted by the institution; and (4) Institutional leadership should mandate sponsor-investigator training and effectively communicate the necessity and availability of training.

    View details for PubMedID 24831858

Footer Links:

Stanford Medicine Resources: